GSK - VERDICT CONSISTENT WITH SCIENTIFIC CONSENSUS THAT THERE IS NO CONSISTENT OR RELIABLE EVIDENCE THAT RANITIDINE INCREASES THE RISK OF ANY CANCER
Gsk - Verdict Consistent With Scientific Consensus That There Is…
![Reuters logo](/images/reuters.jpg)
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,618 GBX | +0.09% |
|
+0.50% | +11.57% |
04:10pm | GSK : Berenberg renews its buy recommendation | CF |
06-19 | GSK : Deutsche Bank remains its Buy rating | ZD |
GSK - VERDICT CONSISTENT WITH SCIENTIFIC CONSENSUS THAT THERE IS NO CONSISTENT OR RELIABLE EVIDENCE THAT RANITIDINE INCREASES THE RISK OF ANY CANCER
1st Jan change | Capi. | |
---|---|---|
+11.57% | 83.89B | |
+54.65% | 803B | |
-6.96% | 351B | |
+18.52% | 324B | |
+10.92% | 303B | |
+16.96% | 243B | |
+2.25% | 228B | |
+11.15% | 217B | |
+6.37% | 164B | |
-3.92% | 155B |